1. Home
  2. PLRX vs SFWL Comparison

PLRX vs SFWL Comparison

Compare PLRX & SFWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • SFWL
  • Stock Information
  • Founded
  • PLRX 2015
  • SFWL 2001
  • Country
  • PLRX United States
  • SFWL China
  • Employees
  • PLRX N/A
  • SFWL N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • SFWL Trucking Freight/Courier Services
  • Sector
  • PLRX Health Care
  • SFWL Industrials
  • Exchange
  • PLRX Nasdaq
  • SFWL Nasdaq
  • Market Cap
  • PLRX 90.9M
  • SFWL 74.2M
  • IPO Year
  • PLRX 2020
  • SFWL 2023
  • Fundamental
  • Price
  • PLRX $1.44
  • SFWL $1.00
  • Analyst Decision
  • PLRX Hold
  • SFWL
  • Analyst Count
  • PLRX 10
  • SFWL 0
  • Target Price
  • PLRX $9.79
  • SFWL N/A
  • AVG Volume (30 Days)
  • PLRX 744.6K
  • SFWL 20.0K
  • Earning Date
  • PLRX 05-20-2025
  • SFWL 05-20-2025
  • Dividend Yield
  • PLRX N/A
  • SFWL N/A
  • EPS Growth
  • PLRX N/A
  • SFWL 4.79
  • EPS
  • PLRX N/A
  • SFWL 0.13
  • Revenue
  • PLRX N/A
  • SFWL $504,158,000.00
  • Revenue This Year
  • PLRX N/A
  • SFWL N/A
  • Revenue Next Year
  • PLRX N/A
  • SFWL N/A
  • P/E Ratio
  • PLRX N/A
  • SFWL $7.58
  • Revenue Growth
  • PLRX N/A
  • SFWL 24.75
  • 52 Week Low
  • PLRX $1.10
  • SFWL $0.81
  • 52 Week High
  • PLRX $16.52
  • SFWL $2.15
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 41.87
  • SFWL 54.73
  • Support Level
  • PLRX $1.36
  • SFWL $0.91
  • Resistance Level
  • PLRX $1.72
  • SFWL $1.03
  • Average True Range (ATR)
  • PLRX 0.11
  • SFWL 0.06
  • MACD
  • PLRX 0.04
  • SFWL 0.01
  • Stochastic Oscillator
  • PLRX 29.17
  • SFWL 88.89

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About SFWL Shengfeng Development Limited

Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services.

Share on Social Networks: